AnGes Inc
TSE:4563
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AnGes Inc
TSE:4563
|
JP |
|
Ryohin Keikaku Co Ltd
F:3RKU
|
JP |
|
Norsk Hydro ASA
OSE:NHY
|
NO |
Intrinsic Value
Is AnGes Inc undervalued or overvalued?
See the intrinsic value estimate for AnGes Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
AnGes Inc looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with AnGes Inc’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What AnGes Does
AnGes Inc. is a Japanese biopharmaceutical company that develops gene-based medicines, with a focus on treatments that use DNA to help the body make therapeutic proteins. Its best-known work has been in areas such as vascular disease, where it has researched gene therapies aimed at improving blood flow, and in vaccines and other DNA-based drug programs. The company does not sell a broad line of consumer products; it is mainly a drug developer that takes scientific ideas through research, testing, and regulatory steps.
- Headquarters
- Japan JP
- Employees
- 56
- IPO date
- Sep 25, 2002
Revenue & Expenses Breakdown
AnGes Inc
Earnings Waterfall
AnGes Inc
The intrinsic value for AnGes Inc (4563) under the Base Case is hidden JPY.
Compared with the current market price of 29 JPY, the stock appears hidden.